Variant report
Variant | nsv603473 |
---|---|
Chromosome Location | chr6:66598249-66636204 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545154268 | chr6:66602617-66602618 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
2 | rs142153221 | chr6:66602639-66602640 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527734621 | chr6:66602669-66602670 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547397489 | chr6:66602679-66602680 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560993041 | chr6:66602692-66602693 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9445616 | chr6:66602722-66602723 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs115115671 | chr6:66602758-66602759 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541667470 | chr6:66602761-66602762 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2351720 | chr6:66602762-66602763 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs151178004 | chr6:66602767-66602768 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549618088 | chr6:66602779-66602780 | ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2351721 | chr6:66602789-66602790 | ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs2351722 | chr6:66602809-66602810 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs533917669 | chr6:66602836-66602837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2351723 | chr6:66602838-66602839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139161057 | chr6:66602850-66602851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566211704 | chr6:66602863-66602864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536230789 | chr6:66602871-66602872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561033618 | chr6:66602926-66602927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2351724 | chr6:66602952-66602953 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs73452394 | chr6:66602967-66602968 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs544881590 | chr6:66602999-66603000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564698880 | chr6:66603004-66603005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs6936593 | chr6:66603071-66603072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574623705 | chr6:66603176-66603177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9351534 | chr6:66603183-66603184 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs78617592 | chr6:66603197-66603198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146411104 | chr6:66603200-66603201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs16897399 | chr6:66603217-66603218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563828021 | chr6:66603220-66603221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181761139 | chr6:66603257-66603258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9342517 | chr6:66603293-66603294 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs9354330 | chr6:66603308-66603309 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs34819170 | chr6:66603316-66603317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535211005 | chr6:66603317-66603318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547553162 | chr6:66603329-66603330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9351535 | chr6:66603336-66603337 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs9345715 | chr6:66603371-66603372 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs376744952 | chr6:66603372-66603373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140794354 | chr6:66603391-66603392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187247296 | chr6:66603398-66603399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs190475552 | chr6:66603467-66603468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9351536 | chr6:66603468-66603469 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs558408379 | chr6:66603480-66603481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs68154106 | chr6:66603487-66603488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571846994 | chr6:66603538-66603539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576152700 | chr6:66603569-66603570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9453474 | chr6:66603577-66603578 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs540793158 | chr6:66603581-66603582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559302075 | chr6:66603634-66603635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66602600-66602800 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr6:66602800-66604600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr6:66609800-66610400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr6:66622600-66623000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr6:66633600-66634000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr6:66633600-66634000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr6:66634000-66634400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
8 | chr6:66634000-66634800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
9 | chr6:66634400-66636000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr6:66634800-66635000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr6:66635000-66635400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr6:66635400-66635800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr6:66635600-66636000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr6:66635600-66636000 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr6:66635600-66636200 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |